In November 2020, Turkovac started on phase I trials with 44 participants in Turkey.[3]
In February 2021, Turkovac started on phase II trials with 250 participants in Turkey.[4]
In June 2021, Turkovac started on phase III trials with 40,800 participants in Turkey.[5] As of 2023[update] phase III trials continue.[6]
Authorization
On 25 November 2021, the Turkish Minister of Health reported that Turkovac's application for emergency use authorization had been filed.[7] On 22 December, Turkish President Recep Tayyip Erdogan announced the emergency use approval of Turkovac.[8]
^Clinical trial number NCT04691947 for "Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine Erucov-Vac" at ClinicalTrials.gov
^Clinical trial number NCT04824391 for "Efficacy, Immunogenicity and Safety of Inactivated Erucov-Vac Compared With Placebo in COVID-19 " at ClinicalTrials.gov
.svg){kind=small}
.png){kind=small}
